Summary

The United Kingdom is at the forefront of developing and implementing new drug screening technologies, such as high-throughput screening (HTS) and next-generation sequencing (NGS). These technologies enable researchers to screen thousands of compounds at the same time and uncover therapeutic candidates more swiftly and efficiently. Personalised medicine is a fast-expanding area that tries to adapt therapies to the individual patient. Drug screening is essential in personalised medicine because it identifies medications that are most successful for specific patient populations. The drug screening industry in the United Kingdom operates within a clearly defined regulatory structure that ensures compliance, accuracy, and ethical practices. The government adheres to recommendations established by organisations such as the Health and Safety Executive (HSE) and the Home Office, which detail precise requirements for drug testing in a variety of industries, notably those involving safety-critical occupations such as transportation and healthcare. This statutory clarity establishes a solid platform for drug screening practices throughout the country. The United Kingdom places a high priority on public health measures for treating substance abuse disorders. Education campaigns, community support programmes, and harm reduction measures are among the approaches. Drug screening is used not only for detection but also as part of larger initiatives to prevent substance usage and its accompanying societal consequences. Drug screening services in the United Kingdom frequently provide customisable solutions to match the unique needs of diverse industries and organisations. Tailored programmes contain varying testing frequencies, specific substance panels, or specialised testing procedures tailored to satisfy the specific needs of various industries, ensuring flexibility and relevance in testing processes.

According to the research report "United Kingdom Drug Screening Market Overview, 2028," published by Bonafide Research, the United Kingdom Drug Screening market is projected to grow with more than 7% CAGR from 2023 to 2028. Collaboration between public health authorities, law enforcement, healthcare providers, and corporate enterprises is an important component of the drug screening environment in the United Kingdom. This collaborative strategy promotes information sharing, coordinated actions, and the creation of comprehensive strategies for effectively combating substance misuse. Public-private collaborations help to synergize resources, knowledge, and skills across sectors. The United Kingdom embraces cutting-edge drug screening technology, such as advances in equipment and analytical methodologies. Point-of-care testing is gaining popularity since it allows for on-site testing with instant findings. These devices are especially useful in emergency situations, outreach programmes, and other situations where quick choices are required. The drug screening practices in the United Kingdom are intended to be inclusive and diverse, taking into account a variety of cultural and societal issues. These factors ensure that testing procedures and protocols are responsive to varied communities and groups while also considering the specific challenges and requirements they may provide. In the United Kingdom, drug screening processes are frequently integrated with mental health assistance efforts. Recognising the interdependence of substance abuse and mental health, particularly in rehabilitation and treatment settings, drug screening programmes may connect individuals to mental health resources to address underlying issues that contribute to substance addiction.

Based on product and services market majorly segmented into consumables, analytical instruments, rapid testing devices, and drug screening service. There is significant increasing demand for analytical instruments in United Kingdom drug screening market. Analytical tools improve drug detection accuracy and sensitivity. Technological advancements in chromatography, mass spectrometry, and immunoassay methods have substantially improved the precision and reliability of drug screening, fulfilling the demand for more precise results. Analytical devices enable a broader variety of testing capabilities, allowing for more specific detection of various substances and their metabolites. These tools aid in comprehensive screens by identifying a wide range of chemicals in a variety of sample types. The drug screening market in the United Kingdom is governed by strict regulatory guidelines. Analytical equipment facilitates compliance with these requirements by offering proven and standardised testing techniques that meet the accuracy, precision, and reliability criteria established by regulatory organisations. In terms of sample type market includes urine samples, breath samples, hair samples, oral fluid samples, and other samples. Oral fluid sample type is expected to grow at rapid pace in United Kingdom drug screening market. In comparison to urine or blood testing, oral fluid sampling is a non-invasive and convenient way of collecting samples. This appeal to both those being screened and those conducting the exams, resulting in greater acceptability and cooperation with testing processes. Collecting oral fluid samples is a straightforward procedure that can be done under direct observation. This ease of collection decreases the possibility of manipulation or substitution, improving the samples' reliability and integrity. Furthermore, the ease with which oral fluid samples can be handled makes them suited for on-site or point-of-care testing. Regulatory agencies in the United Kingdom have accepted and recognised oral fluid testing procedures. They are becoming more standardised and validated, allowing them to meet the demanding quality standards required for drug screening procedures in a variety of industries, including workplace safety and law enforcement.

Based on end user segment market is divided into laboratories, workplaces, hospitals, and others. There is significant rise in demand of drug screening product and services in workplaces. Workplaces prioritise safety, and drug screening is critical to ensuring a safe and secure working environment. Screening assists in identifying persons who are under the influence of drugs, thereby lowering the risk of accidents, injuries, and potential injury to employees, machines, or property. Drug testing protects productivity by detecting and resolving substance misuse problems among employees. Addressing these issues can boost productivity, decrease absenteeism, and improve overall job performance, all of which benefit the company's efficiency and bottom line. Employers undertake drug screens to reduce the liability risks associated with employees who are inebriated or involved with drugs. Employers demonstrate due diligence in preventing potential legal liability stemming from accidents or events caused by substance abuse by conducting screening programmes.

Considered in this report:
• Geography: United Kingdom
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• United Kingdom Drug Screening market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product and Service:
• Consumables
• Analytical Instruments
• Rapid Testing Devices
• Drug Screening Service

By Sample Type:
• Urine Samples
• Breath Samples
• Hair Samples
• Oral Fluid Samples
• Other Samples

By End User:
• Laboratories
• Workplaces
• Hospitals
• Others

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Drug Screening industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

ページTOPに戻る

Table of Contents